Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011

Clinical Microbiology and Infection

Volumn 20, Issue 6, 2014, Pages

  Brolund, A ^a,b   Edquist, P J ^a   Makitalo B ^a   Olsson Liljequist, B ^a   Soderblom T ^a   Wisell, K Tegmark ^a,b   Giske, C G ^a,b,c  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antimicrobial resistance; Enterobacteriaceae; Extended spectrum lactamase; National epidemiology; Surveillance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 2; BETA LACTAMASE CTX M 55; BETA LACTAMASE CTX M 65; BETA LACTAMASE CTX M 96; BETA LACTAMASE SHV; BETA LACTAMASE SHV 1; BETA LACTAMASE SHV 12; BETA LACTAMASE SHV 5; CEFADROXIL; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; COLISTIN; FOSFOMYCIN; GENTAMICIN; MECILLINAM; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SWEDEN; URINE CULTURE; CLUSTER ANALYSIS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SECRETION (PROCESS); VERY ELDERLY; YOUNG ADULT;

ENTEROBACTERIACEAE; ESCHERICHIA COLI;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PREVALENCE; SWEDEN; YOUNG ADULT;

EID: 84904423760     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12413     Document Type: Article

References (30)

1. de Kraker ME, Davey PG, Grundmann H, BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011; 8: e1001104.
2. Lavigne JP, Vergunst AC, Goret L et al. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS ONE 2012; 7: e34294.
3. Helldal L, Karami N, Floren K, Welinder-Olsson C, Moore ER, Ahren C. Shift of CTX-M genotypes has determined the increased prevalence of extended-spectrum β-lactamase-producing Escherichia coli in south-western Sweden. Clin Microbiol Infect 2013; 19: E87-E90.
4. Ostholm-Balkhed A, Tarnberg M, Nilsson M et al. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden. Scand J Infect Dis 2010; 42: 831-838.
5. Stromdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of southern Sweden. Eur J Clin Microbiol Infect Dis 2011; 30: 1159-1162.
6. Kaarme J, Molin Y, Olsen B, Melhus A. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children. Acta Paediatr 2013; 102: 655-660.
7. Giske CG, Sundsfjord AS, Kahlmeter G et al. Redefining extended-spectrum β-lactamases: balancing science and clinical need. J Antimicrob Chemother 2009; 63: 1-4.
8. Birkett CI, Ludlam HA, Woodford N et al. Real-time taqman PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum β-lactamases. J Med Microbiol 2007; 56: 52-55.
9. Brolund A, Wisell KT, Edquist PJ, Elfstrom L, Walder M, Giske CG. Development of a real-time sybrgreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae. J Microbiol Methods 2010; 82: 229-233.
10. Rasheed JK, Jay C, Metchock B et al. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997; 41: 647-653.
11. Hamidian M, Tajbakhsh M, Walther-Rasmussen J, Zali MR. Emergence of extended-spectrum β-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran. Jpn J Infect Dis 2009; 62: 368-371.
12. Onnberg A, Molling P, Zimmermann J, Soderquist B. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden. APMIS 2011; 119: 287-295.
13. Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. Washington, D.C.: ASM Press, 1993.
14. Persing DH. Diagnostic molecular microbiology. Current challenges and future directions. Diagn Microbiol Infect Dis 1993; 16: 159-163.
15. Brolund A, Haeggman S, Edquist PJ et al. The diversilab system versus pulsed-field gel electrophoresis: characterisation of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae. J Microbiol Methods 2010; 83: 224-230.
16. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-4558.
17. Clermont O, Dhanji H, Upton M et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009; 64: 274-277.
18. Wirth T, Falush D, Lan R et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006; 60: 1136-1151.
19. Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemoth 2005; 56: 52-59.
20. Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-3568.
21. Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E. Extended-spectrum β-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis 2010; 42: 275-280.
22. Denisuik AJ, Lagace-Wiens PR, Pitout JD et al. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. J Antimicrob Chemother 2013; 68(Suppl 1): i57-i65.
23. Voets GM, Platteel TN, Fluit AC et al. Population distribution of β-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS ONE 2012; 7: e52102.
24. Kiiru J, Kariuki S, Goddeeris BM, Butaye P. Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period. BMC Microbiol 2012; 12: 155.
25. Matsumura Y, Yamamoto M, Higuchi T et al. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan. Int J Antimicrob Agents 2012; 40: 158-162.
26. Peirano G, Sang JH, Pitondo-Silva A, Laupland KB, Pitout JD. Molecular epidemiology of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae over a 10 year period in Calgary, Canada. J Antimicrob Chemother 2012; 67: 1114-1120.
27. Smet A, Martel A, Persoons D et al. Characterization of extended-spectrum β-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010; 16: 129-134.
28. Aibinu I, Odugbemi T, Koenig W, Ghebremedhin B. Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria. Clin Microbiol Infect 2012; 18: E49-E51.
29. Olesen B, Hansen DS, Nilsson F et al. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum β-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol 2013; 51: 1779-1785.
30. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013; 34: 361-369.